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Abstract
Members of the SLC36 family of proton-coupled amino acid transporters are involved in membrane transport of
amino acids and derivatives. The four transporters show variable tissue expression patterns and are expressed
in various cell types at the plasma-membrane and in intracellular organelles. PAT1 is expressed at the luminal
surface of the small intestine and absorbs amino acids and derivatives [3]. In lysosomes, PAT1 functions as an
efflux mechanism for amino acids produced during intralysosomal proteolysis [2, 15]. PAT2 is expressed at the
apical membrane of the renal proximal tubule [5] and at the plasma-membrane in brown/beige adipocytes [17].
PAT1 and PAT4 are involved in regulation of the mTORC1 pathway [8]. More comprehensive lists of substrates
can be found within the reviews under Further Reading and in the references.
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This is a citation summary for SLC36 family of proton-coupled amino acid transporters in the Guide to
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sections of the database which are given here under database links.
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Database links
SLC36 family of proton-coupled amino acid transporters
http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=223
    Transporters
            PAT1(Proton-coupled Amino acid Transporter 1)
            http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1161
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            PAT2(Proton-coupled Amino acid Transporter 2)
            http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1162
            PAT3(Proton-coupled Amino acid Transporter 3)
            http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1163
            PAT4(Proton-coupled Amino acid Transporter 4)
            http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1164
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